Among individuals with obesity and type 2 diabetes, both medications were associated with lower hazards of anxiety disorders, broadly defined cognitive deficits, mood disorders, and depression
Ipamorelin is more selective and does not appreciably raise cortisol or prolactin, which makes it the most commonly chosen GH secretagogue in current research literature
Address gastro-oesophageal reflux : If reflux is contributing to the bad taste, lifestyle modifications can help
But concerns abound about their potential links to cancer
CagriSema is filed T2D evidence : Tirzepatide has more extensive T2D trial data GI tolerability : CagriSema has higher overall GI event rates Conclusion# CagriSema and tirzepatide represent different strategies to the same goal: surpassing GLP-1-only weight loss
Additionally, they suppress glucagon secretion, a hormone that raises blood glucose levels